Our group previously shown that two novel potential oncogenic genes, PRR11 (proline-rich protein 11) and SKA2, play critical role in cell cycle progression, and accelerate lung cancer cell proliferation, motility and invasion 12, 25, 34, 35. This evidence concerns the gene SKA2 and lung carcinoma.